# OnCo record penile (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/penile/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "penile" ;
  schema:name "Penile cancer"@en ;
  schema:alternateName "Penile squamous cell carcinoma"@en, "Carcinoma of the penis"@en ;
  schema:description "Penile cancer is a squamous skin-type cancer, about half of it caused by HPV. Caught early it is usually cured with organ-sparing surgery that has replaced amputation, and HPV vaccination and circumcision prevent it; the hard cases are those with lymph-node spread, where cisplatin-based chemotherapy plus surgery and now immunotherapy are being tested in the InPACT trial."@en ;
  schema:url <https://onco.cc/cancers/penile/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Penile_cancer> ;
  schema:citation <https://www.cancer.gov/types/penile>, <https://doi.org/10.1016/j.eururo.2023.02.027>, <https://clinicaltrials.gov/study/NCT02305654>, <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1456> ;
  onco:tag "nci-coverage", "rare", "genitourinary", "hpv" ;
  onco:related <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/vulvar/>, <https://onco.cc/cancers/anal/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/cutaneous-scc/> ;
  onco:technologies <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/robotic-surgery/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/tp53/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/drugs/gardasil-9/>, <https://onco.cc/drugs/fluorouracil/> ;
  onco:pathways <https://onco.cc/pathways/oncogenic-viruses/>, <https://onco.cc/pathways/p53-cell-cycle/> ;
  onco:terms <https://onco.cc/terms/hpv-p16/>, <https://onco.cc/terms/hpv-status/>, <https://onco.cc/terms/lymphadenectomy/>, <https://onco.cc/terms/mohs-surgery/> ;
  onco:trials <https://onco.cc/trials/nct06465914/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-rare-cancers/>, <https://onco.cc/bottlenecks/b-prevention-adoption/> ;
  onco:pipeline <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/cemiplimab/>, <https://onco.cc/technologies/hpv-vaccine/> ;
  onco:standardOfCare <https://onco.cc/technologies/brachytherapy/>, <https://onco.cc/terms/mohs-surgery/>, <https://onco.cc/technologies/sentinel-node/>, <https://onco.cc/terms/lymphadenectomy/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/trials/inpact/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/cemiplimab/> .